Janiczek Wealth Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$7.67K Hold
107
﹤0.01% 689
2024
Q1
$7.53K Hold
107
﹤0.01% 717
2023
Q4
$8.26K Buy
107
+35
+49% +$2.31K ﹤0.01% 697
2023
Q3
$4.9K Hold
72
﹤0.01% 726
2023
Q2
$5.88K Sell
72
-27
-27% -$2.17K ﹤0.01% 635
2023
Q1
$8.44K Sell
99
-158
-61% -$12.2K ﹤0.01% 598
2022
Q4
$21.1K Sell
257
-111
-30% -$8.81K 0.01% 452
2022
Q3
$26K Sell
368
-348
-49% -$30.1K 0.01% 415
2022
Q2
$69K Sell
716
-20
-3% -$1.87K 0.02% 259
2022
Q1
$80K Buy
736
+16
+2% +$1.65K 0.02% 241
2021
Q4
$93K Sell
720
-4
-0.6% -$490 0.03% 202
2021
Q3
$88K Buy
724
+60
+9% +$7.3K 0.03% 188
2021
Q2
$75K Buy
664
+32
+5% +$3.37K 0.03% 190
2021
Q1
$60K Buy
632
+84
+15% +$7.66K 0.02% 200
2020
Q4
$44K Buy
548
+504
+1,145% +$36.5K 0.02% 223
2020
Q3
$3K Buy
44
+20
+83% +$1.3K ﹤0.01% 474
2020
Q2
$2K Buy
+24
New +$1.44K ﹤0.01% 307

Other funds holding TECH

Janiczek Wealth Management's TECH Position: Q2 2024 in Review

Janiczek Wealth Management held its Bio-Techne (TECH) position steady in Q2 2024 at 107 shares worth $7.67K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Janiczek Wealth Management first reported a position in TECH in Q2 2020 and has held it in 17 quarters since. The position peaked at $93K in Q4 2021. 571 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

  • Janiczek Wealth Management held 107 shares of Bio-Techne worth $7.67K as of Q2 2024.
  • Janiczek Wealth Management left its Bio-Techne share count unchanged in Q2 2024.
  • Bio-Techne made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #689 holding.
  • Janiczek Wealth Management first reported a position in Bio-Techne in Q2 2020 and has held it in 17 quarters since.
  • Janiczek Wealth Management's Bio-Techne position peaked at $93K in Q4 2021.
  • 571 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.